Please wait while we open this resource.
K
Clinical reviews
ANGIOTENSIN RECEPTOR – NEPRILYSIN INHIBITORS FOR HYPERTENSION — HEMODYNAMIC EFFECTS AND RELEVANCE TO HYPERTENSIVE HEART DISEASE
Medical University
PDF202214 pages442 KB
The article presents evidence on how angiotensin receptor – neprilysin inhibitors, specifically sacubitril/valsartan, effectively reduce blood pressure and improve hemodynamic function in patients with hypertension. It explores the mechanisms through which these inhibitors may protect against target organ damage and contribute to better cardiovascular outcomes. The review also highlights the potential for additive benefits when used in conjunction with other antihypertensive therapies.
Sign in to open
Ask this resource
Answers use this document only.
Your first question is free.
More like this
Resources from the same specialty and type. Curated links will replace these when added.
Clinical Resources
Documents that extend or complement this resource.
SURVIVAL AFTER INITIAL STRESS TESTING VS ANATOMIC TESTING IN SUSPECTED CORONARY ARTERY DISEASE
Same clinical topic · Cardiology
PRACTICAL CARDIO-ONCOLOGY
Same clinical topic · Cardiology
OXFORD CARDIOLOGY LIBRARY: Hypertension
Same clinical topic · Cardiology
CARDIAC INVOLVEMENT IN PARASITIC INFECTIONS
Same clinical topic · Cardiology
The Athlete’s ECG
Same clinical topic · Cardiology
Antigen carbohydrate 125 as a biomarker in heart failure: a narrative review
Same clinical topic · Cardiology
Current ECG Aspects of Interatrial Block
Same clinical topic · Cardiology
Arrhythmic mitral valve prolapse in 2023: Evidence-based update
Same clinical topic · Cardiology
INTERPRETING THE NORMAL PACEMAKER
Same clinical topic · Cardiology